Significant association of a single nucleotide polymorphism in the tumor necrosis factor-alpha (TNF-α) gene promoter with human narcolepsy

Tissue Antigens

Volumn 54, Issue 2, 1999, Pages 138-145

  Hohjoh, Hirohiko ^a   Nakayama, T ^a   Ohashi, J ^a   Miyagawa, T ^a   Tanaka, H ^c   Akaza, T ^c   Honda, Y ^b   Juji, T ^c   Tokunaga, K ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b SEIWA HOSPITAL   (Japan)

^c JAPANESE RED CROSS MEDICAL CENTER   (Japan)

Author keywords

Association study; Narcolepsy; Single nucleotide polymorphism; Tumor necrosis factor alpha

Indexed keywords

HLA DQ ANTIGEN; HLA DR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HUMAN; MALE; NARCOLEPSY; PRIORITY JOURNAL; PROMOTER REGION;

ALLELES; FEMALE; HISTOCOMPATIBILITY TESTING; HUMANS; MALE; NARCOLEPSY; NUCLEOTIDES; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROMOTER REGIONS (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032847223     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.1999.540204.x     Document Type: Article

References (26)

1. Juji T, Satake M, Honda Y, Doi Y. HLA antigens in Japanese patients with narcolepsy - all the patients were DR2 positive. Tissue Antigens 1984: 24: 316-9.
2. Langdon N, Welsh KI, Dam MV, Vaughan RW, Parkes D. Genetic markers in narcolepsy. Lancet 1984: 24: 1178-80.
3. Honda Y, Takahashi Y, Honda M et al. Genetic aspects of narcolepsy. In: Hayaishi O, Inoue S, eds. Sleep and sleep disorders: from molecule to behavior. Tokyo: Academic Press, 1997: 341-58.
4. Mignot E. Genetics of narcolepsy and other sleep disorders. Am J Hum Genet 1997: 60: 1289-302.
5. Wilson AG, di Giovine FS, Blakemore AIF, Duff GW. Single base polymorphism in the human tumor necrosis factor alpha (TNF alpha) gene detectable by Nco I restruction of PCR products. Hum Mol Genet 1992: 1: 353.
6. D'Alfonso S, Richiardi PM. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 1994: 39: 150-4.
7. Braun N, Michel U, Ernst BP et al. Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha) in multiple sclerosis and its influence on the regulation of TNF-alpha production. Neurosci Lett 1996: 215: 75-8.
8. Higuchi T, Seki N, Kamizone S et al. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-a gene in Japanese. Tissue Antigens 1998: 51: 605-12.
9. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 1997: 94: 3195-9.
10. Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 1997: 34: 391-9.
11. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994: 371: 508-10.
12. Cabrera M, Shaw MA, Sharpes C et al. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 1995: 182: 1259-64.
13. Shoham S, Davenne D, Cady AB, Dinarello Ca, Krueger JM. Recombinant tumor necrosis factor and interleukin 1 enhance slow-wave sleep. Am J Physiol 1987: 253: R142-9.
14. Kapás L, Hong L, Cady AB et al. Somnogenic, pyrogenic and anorectic activities of tumor necrosis factor-alpha and TNF-alpha fragments. Am J Physiol 1992: 263: R708-15.
15. Fang J, Wang Y, Krueger JM. Mice lacking the TNF 55 dKa receptor fail to sleep more after TNF alpha treatment. J Neurosci 1997: 17: 5949-55.
16. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997: 82: 1313-6.
17. Matsuki K, Jupi T, Tokunaga K, Naohara T, Satake M, Honda Y. Human histocompatibility leukocyte antigen (HLA) haplotype frequencies estimated from the data on HLA class I, II, III antigens in 111 Japanese narcoleptics. J Clin Invest 1985: 76: 2078-83.
18. Kawai S, Maekawariri S, Tokunage K et al. Routine low and high resolution typing of the HLA-DRB gene using the PCR-MPH (microtiter plate hybridization) method. Eur J Immunogenet 1996: 23: 471-86.
19. Orita M, Iwahann H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci U S A 1989: 86: 2766-70.
20. Bannai M, Tokunaga K, Lin L et al. Discrimination of human HLA-DRB1 alleles by PCR-SSCP (single-strand conformation polymorphism) method. Eur J Immunogenet 1994: 21: 1-9.
21. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T. Estimation of allele and haplotype frequencies for HLA and compliment loci. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991. Vol. 1. Oxford: Oxford University Press, 1992: 76-9.
22. Tokynaga K, Oshikawa Y, Ogawa A et al. Sequence-based association analysis of HLA class I and II alleles in Japanese supports conservation of common haplotypes. Immunogenetics 1997: 46: 199-205.
23. Andreas-Zietz A, Keller E, Schultz S et al. Dr2 negative narcolepsy. Lancet 1986: 2: 684-5.
24. Mueller-Eckhardt G, Meier-Ewert K, Schendel D, Reinecker F, Multhoff G, Mueller-Eckhardt C. HLA and narcolepsy in a German population. Tissue Antigens 1986: 28: 163-9.
25. Mignol E, Lin X, Arrigoni J et al. DQB1*0602 and DQA1*0102 (DQI) are better markers than DR2 for narcolepsy in Caucasian and Black Americans. Sleep 1994: 17: S60-7.
26. Mignot E, Kimura A, Lattermann A et al. HLA class II studies in non-DRB1*1501 patients with narcolepsy-cataplexy. In: Charron D, ed. HLA: Proceedings of 12th International Histocompatibility Workshop and Conference. Paris: EDK, 1997: 1: 436-41.